论文信息 - A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele - 字舞流文

A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

R. Gibson | S. McColley | D. Waltz | B. Ramsey | J. Davies | E. Tullis | C. Wainwright | S. Rowe | S. Moskowitz | J. Taylor-Cousar | M. Mall | E. Zemanick | P. McNally | S. Noel | F. Xuan | S. Tian | J. Rayment | E. McKone | C. Chu | T. Weinstock | N. Ahluwalia | Thang V. Ho | Edith T. Zemanick